Biotechnology News

May 17, 2012

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion is pleased to announce that it has expanded its ADME Suite in Lincoln, Nebraska USA.

May 17, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--New DSA system dramatically reduces analysis time from 25 minutes to 25 seconds by eliminating sample preparation steps for faster, more reliable results and lab workflows

May 17, 2012

EXTON, Penn.--(BUSINESS WIRE)--Patients diagnosed with multiple sclerosis (MS) view themselves as key decision-makers in the management and treatment of MS in equal partnership with their neurologist

May 17, 2012

SANTA CLARA, Calif. & PARIS--(BUSINESS WIRE)--Affymetrix distributes ScreenCell's isolation devices and buffers for Circulating Tumor Cell for cancer research using RNA in situ hybridization assays (RNA ISH) and microarray assays.

May 17, 2012

WOBURN, Mass. & TOKYO--(BUSINESS WIRE)--ArQule and Daiichi Sankyo announced positive Phase 2 clinical data with tivantinib in hepatocellular carcinoma to be presented at ASCO 2012.

May 17, 2012

PARIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced new results from the Medtronic CoreValve ADVANCE Study, which found that women and men benefitted similarly from the Medtronic CoreValve® System. The study, presented at EuroPCR...

May 17, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (“KYTHERA”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market,...

May 17, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (NASDAQ: HGSI) (“HGS” or the “Company”) announced today that its Board of Directors has adopted a Stockholder Rights Plan (the “Rights Plan”) and declared a dividend of one share...

May 17, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is initiating a Phase 2 study evaluating ZEVALIN® (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd).

May 17, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that its Board of Directors, after careful review and consideration with the assistance of the Company’s management and financial and legal advisors, has...

May 17, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2012, and provided financial expectations for its fiscal year 2013, which will be the first full fiscal...

May 17, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals (NASDAQ: SNTA) today announced scheduled presentations at the 2012 ASCO Annual Meeting June 1-5 at the McCormick Place in Chicago.

May 17, 2012

LEXINGTON, Ky.--(BUSINESS WIRE)--MedPro Safety Products, Inc. (OTCBB:MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, will participate in two leading industry conferences...

May 17, 2012

HUDSON, Ohio--(BUSINESS WIRE)--Lexicomp has been selected as the online and mobile drug information provider for the University Health Network (UHN) located in Toronto, Canada.

May 17, 2012

SCHWALBACH, Germany--(BUSINESS WIRE)--BIT Companies is a supporter of “Rays of Hope,” an organization dedicated to providing sustainable aid and a more stable life for underprivileged children in South Africa.

May 16, 2012

SEATTLE--(BUSINESS WIRE)--May 16, 2012--Dendreon Corporation (NASDAQ:DNDN) today announced the following PROVENGE® (sipuleucel-T) data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 1-5,...

May 16, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that data from two of its antibody-drug conjugate (ADC) programs, ADCETRIS (brentuximab vedotin) and ASG-5ME, will be presented at the American Society of...

May 16, 2012

CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) and Astellas Pharma Inc. (TSE:4503) today announced that detailed data from TIVO-1 (Tivozanib Versus Sorafenib in 1st line Advanced RCC), will be presented on June 2 in an...

May 16, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that a quarterly dividend of 10 cents per share of common stock will be paid on July 25 to all shareholders of record as of the close of business on July 3....

May 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that updated clinical data from the pivotal PACE trial of its investigational, pan-BCR-ABL inhibitor, ponatinib, will be presented at the Annual Meeting...

May 16, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

May 16, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Recent technical advances in extrusion technology have enabled multi-layer tubing produced on fully-integrated extrusion lines using closed loop & statistical processes to ensure dimensional control.

May 16, 2012

WASHINGTON--(BUSINESS WIRE)--2012 BIO International Convention will feature a panel of top industry executives to discuss where biotech will be in the next ten years and how the pharmaceutical industry landscape is changing.

May 16, 2012

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn update on CytoFeline

May 16, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the United States Attorney for the District of Massachusetts that federal prosecutors have...

May 16, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced oral presentations on its two MEK inhibitors, selumetinib (AZD6244) and MEK162 at the 2012 ASCO Annual Meeting.

May 16, 2012

LARKSPUR, Calif.--(BUSINESS WIRE)--BioCision LLC, a leader in advanced temperature management of biomedical samples, today announced the presentation of data supporting the need for standardization in stem cell cryopreservation at the...

May 16, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide the latest photos and information on patient three’s...

May 16, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--Florida Biologix provided cGMP manufacturing for the National Taiwan University Hospital's novel gene therapy for a Phase I clinical trial. Results of the AADC trial were published May 16.

May 16, 2012

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it is the only company to receive the NorthFace ScoreBoard Award℠ for ‘world class’ excellence...

May 16, 2012

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Stentys' "APPOSITION III" study results reveal mortality at 1.2% compared to 3.5% in pooled analysis of conventional stents

May 16, 2012

SARNIA, Ontario--(BUSINESS WIRE)--Industry excellence is being celebrated as BioAmber moves steadily toward construction of their full scale, commercial facility in Sarnia, Ontario. BioAmber has been named as an industry leader winning...

May 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Patrick Terry from Scientia Advisors will present insights on Financing, Partnering, and Dealmaking in Stratified Medicine at the Genome-wide Partnering and Deal-making Conference in Boston.

May 16, 2012

HOUSTON--(BUSINESS WIRE)--Aggredyne's first platelet function analyzer, which tests the effectiveness of anti-platelet medications, has received the CE Mark, allowing the sale and use of the AggreGuide A-100 throughout Europe.

May 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, leading the discovery and development of personalized therapeutics for patients with genetically defined cancers, today announced that Dr. Eric Hedrick has joined the company as CMO.

May 16, 2012

PARIS--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: MEDTRONIC IN.PACT DRUG-ELUTING BALLOON STUDIES SHOW SIGNIFICANT BENEFIT OF NOVEL MEDICAL DEVICE IN...

May 16, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Viropro creates biosimilars portfolio

May 16, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Integration between MEDITECH version 5.64 and ProVation® Order Sets enables hospitals to author order sets via the ProVation software, then make them available in MEDITECH’s Physician Care Manager.

May 16, 2012

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation today announced the launch of BROMOscanSM, a new service platform for identification and optimization of inhibitors targeting bromodomain epigenetic “reader” proteins. Developed in a...

May 16, 2012

NEW YORK--(BUSINESS WIRE)--Truveris, Inc. welcomes Michael Jacobs, R.Ph., as VP of National Accounts. Truveris is a health IT SaaS company managing prescription claims data, PBM RFP bidding, and pharmacy cost containment.

May 16, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest retained Ferghana Partners as its strategic transaction advisor to evaluate/implement partnering opportunities on a regional or global basis for the BiovaxID lymphoma cancer vaccine.

May 16, 2012

JERUSALEM--(BUSINESS WIRE)--Marking a major milestone for the company, Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced...

May 16, 2012

MARSEILLE, France--(BUSINESS WIRE)--The French Competitiveness Health Cluster EUROBIOMED is proud to announce that a delegation of SMEs members will attend the ‘Israel Biomed 2012’ on 21st-23rd May 2012, in Tel-Aviv.

May 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals has named hereditary angioedema (HAE) as its lead program. The Company is developing a new class of drug, Cylomimetics, which are peptide-like molecules.

May 16, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter announced the approval of ADVATE for the control and prophylaxis of bleeding episodes in individuals with hemophilia A in China by the State Food and Drug Administration (SFDA).

May 16, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has awarded nearly $300,000 in grants this year to benefit 16 organizations with science, technology, engineering, and mathematics (STEM)...

May 16, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC) announced today that it has signed an exclusive license agreement with The Regents of the University of California, under which it acquired the rights to commercially apply...

May 16, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals from non-petroleum sources, announced the appointment of Ray W. Miller as Chief Business Officer. Mr....